Agios

 

Agios Pharmaceuticals is a public American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias.

  • VP and Head of Clinical Development

  • Senior Medical Director Rare Genetic Disease

  • Head of Rare Disease Clinical Development

  • VP of Global Clinical Operations

  • Medical Director / Senior Medical Director Hematology

  • Director Clinical Science

Previous
Previous

Vaxart (Life sciences)

Next
Next

Acceleron